Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026)

Revolution Medicines' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 38.11% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$1.5 million (up 16.49% YoY), while the FY2025 annual figure was -$957000.0, down 290.61% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$2.1 million, up from -$2.8 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $10.5 million in Q1 2026, with the low at -$6.4 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $2.3 million (2023), against an average of $2.1 million.
• Peak annual rise in Other Working Capital Changes reached 1277.02% in 2025, while the deepest fall reached 1865.88% in 2025.
• Revolution Medicines' Other Working Capital Changes stood at -$2.4 million in 2022, then sank by 143.02% to -$5.9 million in 2023, then jumped by 79.07% to -$1.2 million in 2024, then sank by 125.63% to -$2.8 million in 2025, then climbed by 25.0% to -$2.1 million in 2026.
• Business Quant data shows RVMD's Other Working Capital Changes at -$2.1 million in Q1 2026, -$2.8 million in Q4 2025, and -$4.0 million in Q3 2025.